Podcasts · Lung Cancer Considered

IASLC - TTLC_Molecular Tumor Board

· 55 min

Episode IASLC - TTLC_Molecular Tumor Board

0:00 54:47

In this episode of Lung Cancer Considered, host Dr. Narjust Florez conducts three mock molecular tumor boards with Dr. Misako Nagasaka and Dr. Biagio Ricciuti, live from the Targeted Therapies of Lung Cancer (TTLC) 2026 conference. The discussion addresses the question, “How do we get the right molecular answer, at the right time, for the right patient?”

Guests:

Misako Nagasaka, MD, PhD Associate Clinical Professor University of California, Irvine

Biagio Ricciuti, MD, PhD Thoracic Medical Oncologist, Dana-Farber Cancer Institute Faculty, Harvard School of Medicine

The episode on the publisher’s site

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.